LumiraDx Platform for POC Covid-19 Testing
The LumiraDx Platform simplifies, scales down, and integrates techniques used in laboratory analyzers to provide lab-comparable diagnostic tests on a single point-of-care instrument.
Read MorePosted by Melanie Hamilton-Basich | Feb 24, 2021 | Covid 19 |
The LumiraDx Platform simplifies, scales down, and integrates techniques used in laboratory analyzers to provide lab-comparable diagnostic tests on a single point-of-care instrument.
Read MorePosted by Melanie Hamilton-Basich | Feb 24, 2021 | Covid 19 |
The lateral flow immunoassay test can be used to screen or to aid in diagnoses of covid-19 in asymptomatic or symptomatic individuals.
Read MorePosted by Laurie Bonner | Feb 24, 2021 | Covid 19, Point-of-Care |
Luminostics’ Clip Covid Rapid Antigen Test uses smartphone technology to detect SARS-CoV-2 viral antigens from nasal swabs in around 30 minutes.
Read MorePosted by Laurie Bonner | Feb 24, 2021 | Cancer, Covid 19, Molecular Diagnostics |
Laboratory staffing and supply shortages are limiting patient access to critical cancer screening tests that guide treatment decisions.
Read MorePosted by Melanie Hamilton-Basich | Feb 23, 2021 | Covid 19 |
Laboratory staff working long hours at Penn State’s Department of Pathology are proud of how they’ve adapted to making do with short supplies and heightened demand during the covid-19 pandemic, reports Penn State Health.
Read More